University of East Anglia Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Lancaster University Featured PhD Programmes
"cancer" AND "drugs"×
10 miles

cancer drugs PhD Projects, Programs & Scholarships

We have 70 cancer drugs PhD Projects, Programs & Scholarships

  • "cancer" AND "drugs" ×
  • clear all
Order by 
Showing 1 to 15 of 70
  Cardiotoxicity of cancer drugs targeting the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade
  Prof A Clerk
Applications accepted all year round

Funding Type

PhD Type

"Heart failure is a leading cause of morbidity and mortality worldwide. The contractile cells of the heart, cardiomyocytes, possess many protective mechanisms, allowing them to withstand pathophysiological stresses.
  Transglutaminase 2 (TG2) as a novel cancer biomarker and target for chemotherapy
  Research Group: Biomedical Research Group
  Dr P Coussons, Dr C Pike
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Computational simulation of tumour formation and progression
  Dr D. Goode
Applications accepted all year round

Funding Type

PhD Type

Tumours comprise a complex mix of related but distinct cellular subpopulations that both compete and complement one another. These dynamics strongly influence how and when a tumour forms as well as its response to therapy, however there are hard to observe directly.
  Toxicological Assessment of Carbon Based Nanomaterials
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

The use of sophisticated delivery systems that allow the delivery and targeting of anti-cancer drugs into tumour tissue is an ever expanding area of research.
  Toxicological Assessment of Nanomaterials towards the development of a Nanotoxocicology Framework
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

The use of sophisticated delivery systems that allow the delivery and targeting of anti-cancer drugs into tumour tissue is an ever expanding area of research.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr S Kantamneni
Applications accepted all year round

Funding Type

PhD Type

Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working.
  Bioengineering of patient-derived explants (PDEs) and 3D organoid culture systems for tissue regeneration, cancer and drug discovery
  Dr A Shams Nateri
Applications accepted all year round

Funding Type

PhD Type

The intestine provides an attractive route to model biologically important intestinal processes and a unique opportunity for the direct identification and analysis of factors that contribute to development and maintenance of both normal as well as the development of neoplasia.
  Development of Nano-Enabled Drug Carriers to Overcome Pan-Chemoresistance of Cancer Stem(-like) Cells
  Dr M Najlah
Applications accepted all year round

Funding Type

PhD Type

The acquired resistance induced by repetitive exposure of cancer cells to anticancer drugs is one of the major limitations to successful chemotherapy.
  Understanding the mechanisms of neuroendocrine tumour response to radionuclide therapy
  Prof R Hicks, Assoc Prof C Cullinane
Applications accepted all year round

Funding Type

PhD Type

Neuroendocrine tumours (NET) represent a heterogeneous group of tumours that arise in specialized cells found throughout the body.
  Diagnostic and therapeutic biomarkers in lung cancer
  Dr D CL Lam
Applications accepted all year round

Funding Type

PhD Type

The aim of my research laboratory is to develop and implement new ways to improve the prevention, early detection, diagnosis and treatment of lung cancer through multi-disciplinary research that translates results between the laboratory and the clinic.
  Developing method to rationally design anti-cancer drug combinations
  Prof M Sherman
Applications accepted all year round

Funding Type

PhD Type

Developing novel approaches towards Drug Repurposing and Personalized Medicine. My laboratory is seeking a highly motivated PhD student and a Postdoc to use genetic screens, pathway analysis and other tools to design safe and effective drug combinations.
  Application of protein-drug conjugates for the treatment of cancer (part of the ETN Targeted Anti-Cancer Therapies “TACT”)
  Research Group: Centre for Cancer Research and Cell Biology
  Prof C Scott, Dr K McCloskey
Application Deadline: 1 June 2020

Funding Type

PhD Type

Macromolecular drug substances such as antibodies, ADCs and nanomedicine are often compromised in their therapeutic effectiveness due to inability to penetrate sufficiently into the diseased tissue and be taken up by the diseased cells.
  The role of USP11 in ER+ Breast Cancer
  Prof D O'Connor, Prof T Robson
Applications accepted all year round

Funding Type

PhD Type

De-regulated estrogen receptor (ER) function is a key feature of approximately 70% of breast cancers. Given that the tumourigenic properties of ER primarily lie in its function as a growth-controlling transcription factor, we sought to discover novel modulators of ER transcriptional activity.
  The role of the microenvironment in regulating breast cancer metastatic colonisation
  Dr R Clarke, Dr Ciara O'Brien, Dr R Eyre
Applications accepted all year round

Funding Type

PhD Type

The metastatic spread of breast cancer cells and their colonisation of important organs is the cause of death in 95% of breast cancer.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.